Latin America: Situation and preparedness facing the multi-country human monkeypox outbreak

dc.contributor.authorRodriguez-Morales, Alfonso J.
dc.contributor.authorLopardo, Gustavo
dc.contributor.authorVerbanaz, Sergio
dc.contributor.authorOrduna, Tomas
dc.contributor.authorLloveras, Susana
dc.contributor.authorAzeñas-Burgoa, Jose María
dc.contributor.authorEscalera-Antezana, Juan Pablo
dc.contributor.authorAlvarado-Arnez, Lucia Elena
dc.contributor.authorBarbosa, Alexandre Naime
dc.contributor.authorDiaz-Quijano, Fredi
dc.contributor.authorCimerman, Sergio
dc.contributor.authorChaves, Tânia do Socorro Souza
dc.contributor.authorRodriguez-Morales, Andrea G.
dc.contributor.authorPerret, Cecilia
dc.contributor.authorMéndez, Claudio A.
dc.contributor.authorRiera, Jorge A.
dc.contributor.authorBonilla-Aldana, D. Katterine
dc.contributor.authorCamacho-Moreno, German
dc.contributor.authorMendoza, Henry
dc.contributor.authorRodriguez-Sabogal, Ivan Arturo
dc.contributor.authorOñate, Jose
dc.contributor.authorEscobedo, Angel A.
dc.contributor.authorThormann, Monica
dc.contributor.authorRoque, Yori
dc.contributor.authorZambrano, Patricia Gabriela
dc.contributor.authorCarrero, Yenddy
dc.contributor.authorSandoval, Nancy
dc.contributor.authorZambrano, Lysien
dc.contributor.authorFranco-Paredes, Carlos
dc.contributor.authorChacon-Cruz, Enrique
dc.contributor.authorLopez-Delgado, Iván
dc.contributor.authorCuadra-Sánchez, Cesar
dc.contributor.authorPachar-Flores, Monica
dc.contributor.authorCorrea, Ricardo
dc.contributor.authorRodriguez-Enciso, Hernan D.
dc.contributor.authorRotela-Fisch, Veronica
dc.contributor.authorMaquera-Afaray, Julio
dc.contributor.authorHerrera-Añazco, Percy
dc.contributor.authorBenites-Zapata, Vicente
dc.contributor.authorSavio-Larriera, Eduardo
dc.contributor.authorRamírez, Juan David
dc.contributor.authorPaniz-Mondolfi, Alberto
dc.contributor.authorRisquez, Alejandro
dc.contributor.authorForero-Peña, David A.
dc.contributor.authorTorres, Jaime R.
dc.contributor.authorSuarez, Jose Antonio
dc.date.accessioned2025-04-08T20:43:42Z
dc.date.available2025-04-08T20:43:42Z
dc.date.issued2022-09
dc.description.abstractStill without ceasing the Coronavirus Disease 2019 (COVID-19) pandemic, a new viral threat has now emerged outside its endemic niche in Africa affecting multiple countries and continents. After its appearance in May 2022, a multi-country outbreak of monkeypox disease (MPX) has triggered significant concerns due to its rapid spread and potential for sexual transmission (as suggested by the detection of viral DNA in sexual fluids); this, in addition to the previously known transmission routes described throughout endemic countries of Africa over the last decades or the imported or travel-related cases reported since 2003.1 By June 28, 2022, at least 48 cases in seven Latin American countries (Argentina, Brazil, Chile, Colombia, Mexico, Peru, and Venezuela) have been PCR-confirmed, with at least 16 additional suspected cases (Figure 1).2 Most countries in the region have settled their epidemiological surveillance to detect probable and suspected cases according to national and international case definitions (by the World Health Organization). In addition, the Pan-American Health Organization has issued an epidemiological alert (https://bit.ly/3MUwYNI), with a series of considerations addressing the identification of cases, isolation, follow-up, contact tracing, clinical management, prevention and control. Nevertheless, multiple concerns have been raised, mainly from the healthcare sector, regarding currently available treatments and vaccination. Despite the absence of specific therapeutic alternatives for MPX, drugs with proven experimental efficacy and potential clinical impact such as cidofovir (especially its lipid conjugate brincidofovir) and tecovirimat, are not widely available in the region. Also, although MPX vaccination has been implemented for contacts of positive cases, at this stage, neither non-replicating/replicating-deficient live vaccinia virus-based vaccines with low reactogenicity, such as JYNNEOS®, nor classical anti-smallpox vaccines are available in most Latin American countries.
dc.identifier.citationRodriguez-Morales, A. J., Lopardo, G., Verbanaz, S., Orduna, T., Lloveras, S., Azeñas-Burgoa, J. M., Escalera-Antezana, J. P., Alvarado-Arnez, L. E., Barbosa, A. N., Diaz-Quijano, F., Torres, J. R., & Suarez, J. A. (2022). Latin America: Situation and preparedness facing the multi-country human monkeypox outbreak. The Lancet Regional Health - Americas, 13. https://doi.org/10.1016/j.lana.2022.100318
dc.identifier.urihttps://repositorio.usc.edu.co/handle/20.500.12421/6379
dc.language.isoen
dc.titleLatin America: Situation and preparedness facing the multi-country human monkeypox outbreak
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Latin America Situation and preparedness facing the multi-country human monkeypox outbreak.pdf
Size:
390.8 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: